What You Need to Know: New Study Suggests COVID-19 May Heighten the Risk of Alzheimer’s Disease

New Study Suggests COVID-19 May Increase Risk of Alzheimer’s Disease A recent review in the Journal of Neurochemistry has discovered a potential link between COVID-19 and neurodegenerative diseases such as Alzheimer’s. The study highlights the role of inflammation and aging in connecting viral infections, like COVID-19, with neurodegeneration. Research has shown that age is a […]

Continue Reading

Expansion of Alzheimer’s Diagnosis Options as Medicare Removes Lifetime Limit on PET Scans

Title: Medicare Lifts Lifetime Limit on PET Scans, Expanding Alzheimer’s Diagnosis Options Subtitle: CMS Policy Change Removes Barriers to Accessible Alzheimer’s Diagnostic Tools By Pierre Herubel Image: [Insert Image Description] The US Centers for Medicare and Medicaid Services (CMS) have made an important policy change to remove the lifetime limit on amyloid positron emission tomography […]

Continue Reading